PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dose reduction strategy can substantially reduce high cost of TNF inhibitor therapy in RA

Good clinical response to TNFi maintained when dose reduced by one-third

2015-06-13
(Press-News.org) Rome, Italy, 13 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour necrosis factor inhibitor (TNFi) was maintained even when the dose was reduced by one-third.

Reducing the TNFi dose by two-thirds resulted in more flares (exacerbations of symptoms and signs) but these subsided when the higher dose of TNFi was restarted, and did not adversely affect subsequent progression of any disability. In some cases however, patients maintained a clinical response after stopping the TNFi altogether.

"The optimal management of RA involves achieving the lowest possible disease activity - ideally remission, and then maintaining this level of control," said lead author, Dr. James Galloway, Department of Rheumatology, King's College Hospital NHS Foundation Trust, UK. "Findings from our study have shown that adopting a TNFi dose reduction strategy can still meet this objective, with no compromise on symptom control for the patient and offering a more cost-effective option by substantially reducing the high drug costs associated with TNFi maintenance therapy."

RA is a chronic inflammatory disease characterised by joint inflammation and damage, functional disability and significantly increased mortality. Early intervention using a conventional synthetic disease-modifying anti-rheumatic drug (DMARD) such as methotrexate is critical in preventing structural joint damage and progressive loss of function. For those patients who either fail to respond, or who develop an inadequate response to these drugs over time, a biologic DMARD is an effective add-on treatment option.2 The first choice of biologic therapy is usually a TNFi2 and currently identical dosing regimens of TNFi are used both to induce and then maintain a clinical response.1

Over the first six months of the study, flares (exacerbations of symptoms and signs) occurred in 14% of patients who stayed on the same TNFi dose, compared to a similar figure of 13% in those patients for whom the dose was reduced by one-third. A two-thirds dose reduction increased the odds of a flare occurring by four times compared with a one-third dose reduction, with flares occurring in 37% of patients. Post-dose reduction flares resolved when the original dose of TNFi was restarted. There were no significant differences in self-reported measures of disability (Health Assessment Questionnaire score) with either dose reduction strategy at six months.

The OPTTIRA study is a 12-month multicentre, randomised controlled trial designed to evaluate if reducing TNFi doses (of either etanercept or adalimumab) caused a loss of response in RA patients who were also receiving a synthetic DMARD. To be eligible, patients had to demonstrate stable low disease activity (DAS28 less than 3.2) for over three months. Patients with serious concomitant illness, or those taking high-dose steroids (more than 10mg prednisolone daily) were excluded.

Of the 47 patients who reduced, then stopped their TNFi after six months, 45% (21/47) succeeded without flaring, and their final mean DAS28 score after stopping treatment was 2.2, demonstrating low disease activity.

INFORMATION:

Abstract Number: SAT0150

NOTES TO EDITORS: For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress
Press Office in Room 5B of Fiera Roma during EULAR 2015 or on:
Email: eularpressoffice@cohnwolfe.com
Onsite tel: +44 (0) 7738 890 799 / +44 (0) 20 7331 5442
Twitter: @EULAR_Press
Youtube: Eular Pressoffice

About EULAR The European League Against Rheumatism (EULAR) is an umbrella organisation which represents scientific societies, health professional associations and organisations for people with rheumatic diseases throughout Europe.

EULAR aims to promote, stimulate and support the research, prevention, and treatment of rheumatic diseases and the rehabilitation of those it affects.

With 45 scientific member societies, 35 People with Arthritis and Rheumatism in Europe (PARE) organisations, 19 health professionals associations and 21 corporate members, EULAR highlights the importance of combating rheumatic diseases through both medical means and patient care.

EULAR 2015 is set to be the biggest rheumatology event in Europe with around 14,000 scientists, physicians, allied health professionals and related audiences in attendance from more than 120 countries. Over the course of the congress there will be some 300 oral and just under 2,000 poster abstract presentations, more than 150 sessions, 400 lectures, 40 poster tours and 350 invited speakers.

To find out more about the activities of EULAR, visit: http://www.eular.org



ELSE PRESS RELEASES FROM THIS DATE:

Severely impaired stroke survivors regain arm function after intensive physical therapy

2015-06-13
Time may heal all wounds, but in the case of stroke survivors, the key to better recovery is to spend more time in an intensive physical therapy program, according to a University of Florida Health study. After a stroke, the brain and body can start recovering immediately and can show improvement up to six months afterward, said UF Health researcher Janis Daly, Ph.D. But this study focused on people who had persistent disability even a year or more after completing standard care. The study found that extensive physical therapy helped them recover motor function, even ...

Argonne scientists announce first room-temperature magnetic skyrmion bubbles

Argonne scientists announce first room-temperature magnetic skyrmion bubbles
2015-06-12
New ideas are bubbling up for more efficient computer memory. Researchers at UCLA and the U.S. Department of Energy's Argonne National Laboratory announced today a new method for creating magnetic skyrmion bubbles at room temperature. The bubbles, a physics phenomenon thought to be an option for more energy-efficient and compact electronics, can be created with simple equipment and common materials. Skyrmions, discovered just a few years ago, are tiny islands of magnetism that form in certain materials. If you wrapped one up into a sphere, its magnetic fields would ...

Nearly half of African-American women know someone in prison

2015-06-12
African-American adults -- particularly women -- are much more likely to know or be related to someone behind bars than whites, according to the first national estimates of Americans' ties to prisoners. The research, led by Hedwig Lee, University of Washington associate professor of sociology, reveals the racial inequality wrought by the U.S. prison boom, with potentially harmful consequences to families and communities left lacking social supports for raising children and managing households. In an article published May 20 in the Du Bois Review: Social Science Research ...

UT study compares active video gaming to unstructured outdoor play

2015-06-12
KNOXVILLE--The increasing use of video games is often blamed for children's lack of interest in physical activity, but a study by the University of Tennessee, Knoxville, recently published in the Games for Health Journal suggests that active video games may actually be a source of moderate or intense physical activity in children five to eight years old. "Our study shows video games which wholly engage a child's body can be a source of physical activity," said Hollie Raynor, director of UT's Healthy Eating and Activity Laboratory and associate professor of nutrition. ...

Vitamin D shows promise for treating Crohn's disease in pilot study

2015-06-12
(June 12, 2015) New research published in this month's edition of United European Gastroenterology journal suggests that supplementation with vitamin D may impact on the intestinal barrier dysfunction associated with Crohn's disease, and could have a role in the treatment of the condition. The study is by Professor Maria O'Sullivan and Tara Raftery. Department of Clinical Medicine, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland. Crohn's disease (CD) is a lifelong chronic relapsing and remitting gastrointestinal condition, characterised by inflammation, ...

Disney research creates click-and-drag interface enabling rapid video object segmentation

2015-06-12
Investigators at Disney Research Zurich have developed a method for achieving very accurate object segmentation of video by enabling human editors to work efficiently with state-of-the-art algorithms using a click-and-drag interface. Segmentation, which identifies objects, backgrounds and other meaningful regions within an image or video, is a necessary step for many editing tasks and for image analysis. People can readily perceive objects and the composition of scenes despite variations in colors, lighting and contours, but despite significant advances in recent years, ...

Behavior matters: Redesigning the clinical trial

2015-06-12
When a new type of drug or therapy is discovered, double-blind randomized controlled trials (DBRCTs) are the gold standard for evaluating them. These trials, which have been used for years, were designed to determine the true efficacy of a treatment free from patient or doctor bias, but they do not factor in the effects that patient behaviors, such as diet and lifestyle choices, can have on the tested treatment. A recent meta-analysis of six such clinical trials, led by Caltech's Erik Snowberg, professor of economics and political science, and his colleagues Sylvain Chassang ...

Stone tools from Jordan point to dawn of division of labor

Stone tools from Jordan point to dawn of division of labor
2015-06-12
Thousands of stone tools from the early Upper Paleolithic, unearthed from a cave in Jordan, reveal clues about how humans may have started organizing into more complex social groups by planning tasks and specializing in different technical skills. The Journal of Human Evolution published a study of the artifacts from Mughr el-Hamamah, or Cave of the Doves, led by Emory University anthropologists Liv Nilsson Stutz and Aaron Jonas Stutz. "We have achieved remarkably accurate estimates of 40,000 to 45,000 years ago for the earliest Upper Paleolithic stone tools in the ...

ED worsened, testosterone levels decreased by some treatments of prostate enlargement

2015-06-12
(Boston)--Men with benign prostate enlargement who used finasteride (also known as proscar and propecia) to treat their condition, experienced worsening erectile dysfunction (ED) that did not resolve with continued treatment. In addition, they experienced a reduction in their testosterone levels leading to hypogonadism (little to no production of sex hormones). However, men who used tamsulosin (flomax) experienced none of these adverse side effects. The findings, currently available online in the journal Hormone Molecular Biology and Clinical Investigation, were led by ...

We are entering a 'golden age' of animal tracking

We are entering a golden age of animal tracking
2015-06-12
Animals wearing new tagging and tracking devices give a real-time look at their behavior and at the environmental health of the planet, say research associates at the Smithsonian Tropical Research Institute in the June 12 issue of Science magazine. "We suggest that a golden age of animal tracking science has begun," they predict. "The upcoming years will be a time of unprecedented, exciting discoveries." Driven, in part, by consumer demand in the past five years, radio-tracking technology has been replaced by smaller GPS tags that allow scientists to accurately track ...

LAST 30 PRESS RELEASES:

Natural supplement may decrease biological aging and improve muscle strength

Ursolic acid modulates estrogen conversion to relieve inflammation in metabolic dysfunction-associated steatotic liver disease via HSD17B14

New research highlights how parental awe and pride enhance well-being

Protecting audio privacy at the source

Omnivorous? Vegan? Makes no difference to muscle building after weight training, study finds

More ticks carry Lyme disease bacteria in pheasant-release areas

Older adults respond well to immunotherapy despite age-related immune system differences

Study reveals new genetic mechanism behind autism development

The puberty talk: Parents split on right age to talk about body changes with kids

Tusi (a mixture of ketamine and other drugs) is on the rise among NYC nightclub attendees

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

[Press-News.org] Dose reduction strategy can substantially reduce high cost of TNF inhibitor therapy in RA
Good clinical response to TNFi maintained when dose reduced by one-third